Cargando…
Repressing the repressor: Ezh2 mediates macrophage activation
In this issue of JEM, Zhang et al. (https://doi.org/10.1084/jem.20171417) show that the suppressive epigenetic enzyme Ezh2 is an important regulator of macrophage activation. The absence of Ezh2 leads to reduced cytokine secretion and suppresses macrophage-dependent disease development. They identif...
Autores principales: | Neele, Annette E., de Winther, Menno P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940273/ https://www.ncbi.nlm.nih.gov/pubmed/29691302 http://dx.doi.org/10.1084/jem.20180479 |
Ejemplares similares
-
Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
por: Neele, Annette E., et al.
Publicado: (2021) -
Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites
por: Dekkers, Koen F., et al.
Publicado: (2019) -
Targeting epigenetics as atherosclerosis treatment: an updated view
por: Neele, Annette E., et al.
Publicado: (2020) -
Dual roles of EZH2 in acute myeloid leukemia
por: Skoda, Radek C., et al.
Publicado: (2019) -
Macrophage subsets in atherosclerosis as defined by single‐cell technologies
por: Willemsen, Lisa, et al.
Publicado: (2020)